Transnational Corporations Eye Traditional Chinese Medicine Biz (China)
This article was originally published in PharmAsia News
Executive Summary
In the past 10 years there has been increasing global interest in the uses of traditional Chinese medicine (TCM), particularly in the country's vast supply of medicinal plants. According to a study by the Beijing Pharmaceutical Professional Association, the world's 15 leading pharmaceutical companies have increased their research into plant-based medications by 22 percent. Regulatory bodies around the world have also relaxed regulations on TCM products, leading more international companies to invest in their development. (Print Edition Only: Link to Full Text Unavailable
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.